Wade M. Aubry, MD

Articles

November 13th 2018

Understanding and Improving Value Frameworks With Real-World Patient Outcomes

Anupam B. Jena, MD, PhD Jacquelyn W. Chou, MPP, MPL Lara Yoon, MPH Wade M. Aubry, MD Jan Berger, MD, MJ Wayne Burton, MD A. Mark Fendrick, MD Donna M. Fick, RN, PhD David Franklin, BA Rebecca Killion, MA Darius N. Lakdawalla, PhD Peter J. Neumann, ScD Kavita Patel, MD, MSHS John Yee, MD, MPH Brian Sakurada, PharmD Kristina Yu-Isenberg, PhD, MPH, RPh

New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.

December 5th 2016

The Social Value of Childhood Vaccination in the United States

Tomas J. Philipson, PhD Julia Thornton Snider, PhD Ayman Chit, PhD Sarah Green, BA Philip Hosbach, BA Taylor Tinkham Schwartz, MPH Yanyu Wu, PhD Wade M. Aubry, MD

Vaccination of children born in the United States in 2009 will save 1.2 million quality-adjusted life-years, generating $184 billion in social value net of vaccination costs.

August 12th 2013

Session 2: Discussant

Wade M. Aubry, MD

Wade M. Aubry, MD, associate clinical professor, University of California, San Francisco, continues discussions saying that comparative effectiveness research (CER) and the evolution of evidence-based medicine can facilitate innovations under the Affordable Care Act (ACA), especially with the inclusion of value-based insurance design (VBID).